Previous Close | 58.23 |
Open | 58.35 |
Bid | 58.80 x 1800 |
Ask | 58.94 x 1100 |
Day's Range | 57.62 - 58.92 |
52 Week Range | 39.35 - 61.08 |
Volume | |
Avg. Volume | 10,999,515 |
Market Cap | 119.399B |
Beta (5Y Monthly) | 0.44 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.58 |
Earnings Date | Feb 06, 2025 |
Forward Dividend & Yield | 2.40 (4.08%) |
Ex-Dividend Date | Oct 04, 2024 |
1y Target Est | 59.37 |
There's no doubt that investing in the stock market is a truly brilliant way to build wealth. But not every stock you...
Investors often look to major pharmaceutical stocks as an area that is likely to provide an anchor for their portfolios. Consider Bristol Myers Squibb (NYSE: BMY), which has seen its shares rise just 2% over the past five years, seesawing back and forth over that time. Its trailing-12-month operating expenses of $28.2 billion are substantially higher than its operating income of around $7.3 billion over that period.